| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_129e393582e6bdf4029baf2206522f45 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L2430-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L2400-10 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L31-048
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L31-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C08L83-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L29-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L29-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L29-041
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G02C7-049
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L27-50
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C08L33-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G02B1-043
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L15-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L15-26
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L26-0014
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L26-0019
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L27-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L27-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L31-14 |
| classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C08F222-36 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L27-44
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L27-34 |
| filingDate |
2019-12-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4fead8c5c08dd22a5d63b98b95bbc9b0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9d0ef2e04fc26d732881cea819937ea0 |
| publicationDate |
2020-09-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
TW-202031302-A |
| titleOfInvention |
Medical device |
| abstract |
A medical device with an internal wetting agent and a copolymer of silicone monomers and meeting the following requirements; (1) The internal wetting agent includes a copolymer of chain compounds having acidic groups and amide groups; (2) ) The internal wetting agent is contained in the range of 0.1-10% by mass relative to the entire medical device; (3) The copolymer of the polysiloxane monomer has a hydroxyl group, and the hydroxyl group in the polysiloxane monomer contains The ratio is in the range of 0.0005 to 0.01 equivalent/g. A medical device containing an internal wetting agent with excellent transparency and hydrophilicity can be obtained. |
| priorityDate |
2018-12-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |